A journal author defends his research methodology on quality-adjusted life years, arguing that the measurement is imprecise but necessary in order to determine the impact of clinical interventions and cost-effectiveness of new health care technologies.
Research findings indicate that an endocrinologist's treatment of patients hospitalized with diabetic ketoacidosis is more cost-effective than general physicians' treatment of those patients due to greater experience in specialized treatment.